Weiwei Chen1, Timothy F Page2, Wenjie Sun3. 1. Department of Economics, Finance and Quantitative Analysis, Michael J. Coles College of Business, Kennesaw State University, 560 Parliament Garden Way, Kennesaw, GA, 30144, USA. wchen30@kennesaw.edu. 2. Department of Management, H. Wayne Huizenga College of Business and Entrepreneurship, Nova Southeastern University, 3301 College Ave, Davie, FL, 33314, USA. 3. Robert Stempel College of Public Health & Social Work, Florida International University, 11200 SW 8th St, Miami, FL, 33199, USA.
Abstract
OBJECTIVES: To examine the role of individual race/ethnicity and community racial/ethnic mix on the type of opioid-related emergency department (ED) visits in Florida. METHODS: The study identifies opioid-related ED visits that involved heroin, non-heroin poisoning, and opioid use disorder (OUD) from the first quarter of 2010 to the second quarter of 2018 in Florida. The trend is depicted by patients' race/ethnicity and racial/ethnic mix of residential communities. Combined with zip code tabulation area data, the study builds a multilevel model and examines how individual-level and community-level covariates relate to the type of opioid-related ED visits. RESULTS: While opioid-related ED visit rate was highest among white patients, majority-black communities caught up with the majority-white communities in the visit rate. The multilevel model results suggest that the likelihood of an opioid-related ED visit involving heroin, non-heroin poisoning, or OUD differed by patient race/ethnicity as well as community racial/ethnic mix. Opioid-related ED visits among minority patients were more likely to involve non-heroin poisoning than non-Hispanic white patients, whereas patients from minority-dominant communities were more likely to involve heroin poisoning than from majority-white communities. However, community racial/ethnic mix was not significantly or less significantly associated with the likelihood of involving OUD ED visits. CONCLUSIONS: The study highlights the heterogeneity of the opioid overdose problem across racial/ethnic patients and communities with different racial/ethnic mixes. Future policies may consider the effect of living in different racial/ethnic mixed communities in addition to individual race/ethnicity.
OBJECTIVES: To examine the role of individual race/ethnicity and community racial/ethnic mix on the type of opioid-related emergency department (ED) visits in Florida. METHODS: The study identifies opioid-related ED visits that involved heroin, non-heroin poisoning, and opioid use disorder (OUD) from the first quarter of 2010 to the second quarter of 2018 in Florida. The trend is depicted by patients' race/ethnicity and racial/ethnic mix of residential communities. Combined with zip code tabulation area data, the study builds a multilevel model and examines how individual-level and community-level covariates relate to the type of opioid-related ED visits. RESULTS: While opioid-related ED visit rate was highest among white patients, majority-black communities caught up with the majority-white communities in the visit rate. The multilevel model results suggest that the likelihood of an opioid-related ED visit involving heroin, non-heroin poisoning, or OUD differed by patient race/ethnicity as well as community racial/ethnic mix. Opioid-related ED visits among minority patients were more likely to involve non-heroin poisoning than non-Hispanic white patients, whereas patients from minority-dominant communities were more likely to involve heroin poisoning than from majority-white communities. However, community racial/ethnic mix was not significantly or less significantly associated with the likelihood of involving OUD ED visits. CONCLUSIONS: The study highlights the heterogeneity of the opioid overdose problem across racial/ethnic patients and communities with different racial/ethnic mixes. Future policies may consider the effect of living in different racial/ethnic mixed communities in addition to individual race/ethnicity.
Authors: Crystal M Fuller; Luisa N Borrell; Carl A Latkin; Sandro Galea; Danielle C Ompad; Steffanie A Strathdee; David Vlahov Journal: Am J Public Health Date: 2005-04 Impact factor: 9.308
Authors: Alene Kennedy-Hendricks; Matthew Richey; Emma E McGinty; Elizabeth A Stuart; Colleen L Barry; Daniel W Webster Journal: Am J Public Health Date: 2015-12-21 Impact factor: 9.308
Authors: Carmen R Green; Karen O Anderson; Tamara A Baker; Lisa C Campbell; Sheila Decker; Roger B Fillingim; Donna A Kalauokalani; Donna A Kaloukalani; Kathyrn E Lasch; Cynthia Myers; Raymond C Tait; Knox H Todd; April H Vallerand Journal: Pain Med Date: 2003-09 Impact factor: 3.750
Authors: Lainie Rutkow; Hsien-Yen Chang; Matthew Daubresse; Daniel W Webster; Elizabeth A Stuart; G Caleb Alexander Journal: JAMA Intern Med Date: 2015-10 Impact factor: 21.873
Authors: Scott G Weiner; Aleta D Carroll; Nicholas M Brisbon; Claudia P Rodriguez; Charles Covahey; Erin J Stringfellow; Catherine DiGennaro; Mohammad S Jalali; Sarah E Wakeman Journal: J Subst Abuse Treat Date: 2022-04-30